Chenting Zhang

State Key Laboratory Of Respiratory Disease, Guangdong Key Laboratory Of Vascular Disease
China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.

Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: June 06, 2025

Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.

Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.

Journal: Respiratory research

Published: February 06, 2025

Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.

Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: January 06, 2025

A study on the genetic comorbidity between autoimmune diseases and pulmonary hypertension: an observational study and POST-GWAS analysis.

A study on the genetic comorbidity between autoimmune diseases and pulmonary hypertension: an observational study and POST-GWAS analysis.

Journal: International journal of medical sciences

Published: November 29, 2024

Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.

Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.

Journal: Physiological reports

Published: October 07, 2024

Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.

Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.

Journal: BMC medicine

Published: August 18, 2024

Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.

Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.

Journal: Respiratory research

Published: February 07, 2024

Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease.

Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease.

Journal: Respiratory research

Published: August 09, 2023

Impacts of anaesthesia strategies on mouth-lung microbial signature: Evidence from bronchoscopy sampling and sequencing.

Impacts of anaesthesia strategies on mouth-lung microbial signature: Evidence from bronchoscopy sampling and sequencing.

Journal: Clinical and translational medicine

Published: February 16, 2023

Respiratory Microbiome Profile of Pediatric Pulmonary Hypertension Patients Associated With Congenital Heart Disease.

Respiratory Microbiome Profile of Pediatric Pulmonary Hypertension Patients Associated With Congenital Heart Disease.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: November 10, 2022

Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension.

Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension.

Journal: Thrombosis research

Published: April 29, 2022

Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.

Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.

Journal: Microbiological research

Published: February 01, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026